Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.33 USD | +8.11% | +8.28% | -4.69% |
05-21 | JPMorgan Starts Structure Therapeutics With Overweight Rating | MT |
05-09 | Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.69% | 1.7B | |
+11.23% | 115B | |
+12.61% | 106B | |
-4.23% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.17% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+32.19% | 12.13B |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- Piper Sandler Raises Price Target on Structure Therapeutics to $93 From $58, Maintains Overweight Rating